Showing: 1 - 4 of 4 RESULTS
Biotech Briefing Psychedelics Revive Therapeutics

Revive Therapeutics Announces Research Collaboration Agreement For Psilocybin Microneedle Patch

Revive Therapeutics (CSE: RVV) announced today that it has entered into a research collaboration agreement with PharmaTher Holdings Ltd. (CSE: PHRM). The agreement seeks to evaluate delivering psilocybin with the latter’s microneedle patch technology for treating neuropsychiatric disorders. PharmaTher is conducting studies with MicroDose-MN–a biocompatible and biodegradable gelatin methacryloyl microneedle patch to deliver psilocybin. The studies …

Biotech Briefing Bright Minds Biosciences Full Analysis Psychedelics

Bright Minds Biosciences: Corporate Overview

Bright Minds Biosciences Inc. (CSE: DRUG) is a small-cap preclinical biosciences company that is attempting to create the next generation of serotonin drugs that will target specific conditions in the brain which lead to mental health problems and neurological ailments. Serotonin is the key hormone which stabilizes our mood, feelings of well-being and happiness. Even more, it allows …

Biotech Briefing COVID-19 Psychedelics Revive Therapeutics

Revive Submits for IRB Approval; Expects to Enroll Patients in September

This morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial protocol to their independent Institutional Review Board (IRB) for approval. The company also announced they expect to have patients enrolled in September 2020. What is an IRB? An institutional review board is an appropriately constituted group that has been formally designated …